Abdelhamed W, El-Kassas M
Liver Res. 2025; 7(4):321-332.
PMID: 39958776
PMC: 11791921.
DOI: 10.1016/j.livres.2023.11.004.
Zhi R, Li Q, Zhang H, Fan F
Mol Carcinog. 2025; 64(4):744-755.
PMID: 39835603
PMC: 11890426.
DOI: 10.1002/mc.23884.
Nadda N, Yadav R, Roy N, Singh N, Kumar S, Paul S
Front Immunol. 2024; 15:1459749.
PMID: 39703498
PMC: 11656047.
DOI: 10.3389/fimmu.2024.1459749.
Ye C, Ou M, Wen Z, Xu B, Lu T, Guo Y
World J Surg Oncol. 2024; 22(1):260.
PMID: 39342303
PMC: 11439314.
DOI: 10.1186/s12957-024-03538-8.
Wang Y, Ma X, Zou Y, Yue M, Zhang M, Yu R
J Biomed Res. 2024; :1-10.
PMID: 38808546
PMC: 11461531.
DOI: 10.7555/JBR.37.20230284.
Hepatocellular Carcinoma: Prevention, Diagnosis, and Treatment.
Feng F, Zhao Y
Med Princ Pract. 2024; 33(5):414-423.
PMID: 38772352
PMC: 11460940.
DOI: 10.1159/000539349.
Plumbagin Regulates Snail to Inhibit Hepatocellular Carcinoma Epithelial-Mesenchymal Transition in vivo and in vitro.
Du Y, Yuan B, Ye Y, Zhou F, Liu H, Huang J
J Hepatocell Carcinoma. 2024; 11:565-580.
PMID: 38525157
PMC: 10960549.
DOI: 10.2147/JHC.S452924.
Activated hedgehog gene pattern correlates with dismal clinical outcome and tumor microenvironment heterogeneity in hepatocellular carcinoma.
Zhen L, Zhu Y, Wu Z, Liao J, Deng L, Ma Q
Heliyon. 2024; 10(5):e26989.
PMID: 38468970
PMC: 10926087.
DOI: 10.1016/j.heliyon.2024.e26989.
HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
Attallah K, Albannan M, Farid K, Rizk S, Fathy N
Technol Cancer Res Treat. 2024; 23:15330338241234790.
PMID: 38436112
PMC: 10913511.
DOI: 10.1177/15330338241234790.
Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers.
Li Y, Sui S, Goel A
Semin Cancer Biol. 2024; 99:5-23.
PMID: 38341121
PMC: 11774199.
DOI: 10.1016/j.semcancer.2024.02.001.
The role of long non-coding RNA in hepatocellular carcinoma.
Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J
Aging (Albany NY). 2024; 16(4):4052-4073.
PMID: 38334963
PMC: 10929815.
DOI: 10.18632/aging.205523.
Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment.
Brusset B, Jacquemin M, Teyssier Y, Roth G, Sturm N, Roustit M
JHEP Rep. 2024; 6(1):100957.
PMID: 38234407
PMC: 10792651.
DOI: 10.1016/j.jhepr.2023.100957.
Inflammatory Markers Showed Significant Incremental Value for Predicting Post-Hepatectomy Liver Failure in Hepatocellular Carcinoma Patients.
Wang X, Wang W, Lin X, Chen X, Zhu M, Xu H
Life (Basel). 2023; 13(10).
PMID: 37895372
PMC: 10607941.
DOI: 10.3390/life13101990.
Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma.
Yu S, Zhao R, Zhang B, Lai C, Li L, Shen J
Asian J Pharm Sci. 2023; 18(4):100828.
PMID: 37583709
PMC: 10424087.
DOI: 10.1016/j.ajps.2023.100828.
Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting.
Aly A, Fulcher N, Seal B, Pham T, Wang Y, Paulson S
Hepat Oncol. 2023; 10(1):HEP47.
PMID: 37577406
PMC: 10413176.
DOI: 10.2217/hep-2023-0002.
Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma.
Wenpei G, Yuan L, Liangbo L, Jingjun M, Bo W, Zhiqiang N
Front Oncol. 2023; 13:1142168.
PMID: 37519805
PMC: 10373589.
DOI: 10.3389/fonc.2023.1142168.
Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment.
Chang P, Lee R, Liang P, Liu Y, Chuang V, Wu D
Front Oncol. 2023; 13:1186674.
PMID: 37427137
PMC: 10328116.
DOI: 10.3389/fonc.2023.1186674.
Prognostic value of systemic immune-inflammation index/ albumin for transcatheter arterial chemoembolization treatment.
Tian Y, Ma L, Zhang P, Liu S, Luo X, Wu L
Heliyon. 2023; 9(4):e15156.
PMID: 37151715
PMC: 10161375.
DOI: 10.1016/j.heliyon.2023.e15156.
Microbiome and Metabolomics in Liver Cancer: Scientific Technology.
Ganesan R, Yoon S, Suk K
Int J Mol Sci. 2023; 24(1).
PMID: 36613980
PMC: 9820585.
DOI: 10.3390/ijms24010537.
Using arterial phase hyperenhancement on CT instead of gadoxetic acid arterial phase enhancement may improve the diagnostic performance for hepatocellular carcinoma.
Tang H, Gao F, Wei Y, Deng L, Li Q, Yuan Y
Ann Transl Med. 2022; 10(22):1229.
PMID: 36544692
PMC: 9761133.
DOI: 10.21037/atm-22-4968.
